Annual Shareholders Equity
$921.52 M
+$35.31 M+3.98%
December 31, 2023
Summary
- As of February 7, 2025, SUPN annual stockholders equity is $921.52 million, with the most recent change of +$35.31 million (+3.98%) on December 31, 2023.
- During the last 3 years, SUPN annual shareholders equity has risen by +$176.66 million (+23.72%).
- SUPN annual shareholders equity is now at all-time high.
Performance
SUPN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.01 B
+$49.70 M+5.19%
September 30, 2024
Summary
- As of February 7, 2025, SUPN quarterly stockholders equity is $1.01 billion, with the most recent change of +$49.70 million (+5.19%) on September 30, 2024.
- Over the past year, SUPN quarterly shareholders equity has increased by +$94.96 million (+10.41%).
- SUPN quarterly shareholders equity is now at all-time high.
Performance
SUPN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SUPN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | +10.4% |
| 3 y3 years | +23.7% | +10.4% |
| 5 y5 years | +103.4% | +10.4% |
SUPN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.9% | at high | +23.4% |
| 5 y | 5-year | at high | +54.8% | at high | +69.2% |
| alltime | all time | at high | +2179.2% | at high | +1488.7% |
Supernus Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.01 B(+5.2%) |
| Jun 2024 | - | $957.45 M(+3.0%) |
| Mar 2024 | - | $929.17 M(+0.8%) |
| Dec 2023 | $921.52 M(+4.0%) | $921.52 M(+1.0%) |
| Sep 2023 | - | $912.19 M(-0.8%) |
| Jun 2023 | - | $919.91 M(+0.9%) |
| Mar 2023 | - | $912.15 M(+2.9%) |
| Dec 2022 | $886.20 M(+8.6%) | $886.20 M(+3.9%) |
| Sep 2022 | - | $852.80 M(+1.4%) |
| Jun 2022 | - | $841.43 M(+1.6%) |
| Mar 2022 | - | $828.45 M(+1.5%) |
| Dec 2021 | $815.85 M(+9.5%) | $815.85 M(+0.7%) |
| Sep 2021 | - | $810.47 M(+3.2%) |
| Jun 2021 | - | $785.58 M(+4.1%) |
| Mar 2021 | - | $754.44 M(+1.3%) |
| Dec 2020 | $744.86 M(+25.1%) | $744.86 M(+5.1%) |
| Sep 2020 | - | $708.88 M(+6.4%) |
| Jun 2020 | - | $665.97 M(+8.6%) |
| Mar 2020 | - | $613.38 M(+3.0%) |
| Dec 2019 | $595.43 M(+31.4%) | $595.43 M(+6.8%) |
| Sep 2019 | - | $557.26 M(+6.6%) |
| Jun 2019 | - | $522.90 M(+8.9%) |
| Mar 2019 | - | $480.02 M(+6.0%) |
| Dec 2018 | $453.02 M(+69.4%) | $453.02 M(+7.4%) |
| Sep 2018 | - | $421.94 M(+8.1%) |
| Jun 2018 | - | $390.49 M(+11.0%) |
| Mar 2018 | - | $351.87 M(+31.5%) |
| Dec 2017 | $267.48 M | $267.48 M(+6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $251.66 M(+9.7%) |
| Jun 2017 | - | $229.40 M(+11.3%) |
| Mar 2017 | - | $206.06 M(+7.5%) |
| Dec 2016 | $191.75 M(+117.9%) | $191.75 M(+10.6%) |
| Sep 2016 | - | $173.37 M(+22.9%) |
| Jun 2016 | - | $141.02 M(+10.1%) |
| Mar 2016 | - | $128.14 M(+45.6%) |
| Dec 2015 | $88.01 M(+116.2%) | $88.01 M(-19.6%) |
| Sep 2015 | - | $109.44 M(+6.9%) |
| Jun 2015 | - | $102.36 M(+8.2%) |
| Mar 2015 | - | $94.58 M(+132.4%) |
| Dec 2014 | $40.70 M(+21.6%) | $40.70 M(-38.4%) |
| Sep 2014 | - | $66.12 M(+98.1%) |
| Jun 2014 | - | $33.37 M(+15.0%) |
| Mar 2014 | - | $29.01 M(-13.3%) |
| Dec 2013 | $33.46 M(-41.9%) | $33.46 M(+168.7%) |
| Sep 2013 | - | $12.45 M(-65.3%) |
| Jun 2013 | - | $35.89 M(-13.0%) |
| Mar 2013 | - | $41.27 M(-28.3%) |
| Dec 2012 | $57.57 M(+509.7%) | $57.57 M(+133.7%) |
| Sep 2012 | - | $24.63 M(-35.1%) |
| Jun 2012 | - | $37.98 M(>+9900.0%) |
| Mar 2012 | - | $274.00 K(-97.1%) |
| Dec 2011 | $9.44 M(-121.3%) | $9.44 M(-113.0%) |
| Sep 2011 | - | -$72.52 M(+63.6%) |
| Dec 2010 | -$44.32 M(+619.9%) | -$44.32 M(+23.4%) |
| Sep 2010 | - | -$35.92 M(+483.4%) |
| Dec 2009 | -$6.16 M(-8.8%) | -$6.16 M |
| Dec 2008 | -$6.75 M | - |
FAQ
- What is Supernus Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual shareholders equity year-on-year change?
- What is Supernus Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Supernus Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of SUPN is $921.52 M
What is the all time high annual shareholders equity for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual stockholders equity is $921.52 M
What is Supernus Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, SUPN annual stockholders equity has changed by +$35.31 M (+3.98%)
What is Supernus Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of SUPN is $1.01 B
What is the all time high quarterly shareholders equity for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly stockholders equity is $1.01 B
What is Supernus Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, SUPN quarterly stockholders equity has changed by +$94.96 M (+10.41%)